UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy

Simoes, Fabio A; Joilin, Greig; Peters, Oliver; Schneider, Luisa-Sophie; Priller, Josef; Spruth, Eike Jakob; Vogt, Ina; ... Hafezparast, Majid; + view all (2022) Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy. International Journal of Molecular Sciences , 23 (23) , Article 14554. 10.3390/ijms232314554. Green open access

[thumbnail of ijms-23-14554.pdf]
Preview
Text
ijms-23-14554.pdf - Published Version

Download (1MB) | Preview

Abstract

Objective markers for the neurodegenerative disorder progressive supranuclear palsy (PSP) are needed to provide a timely diagnosis with greater certainty. Non-coding RNA (ncRNA), including microRNA, piwi-interacting RNA, and transfer RNA, are good candidate markers in other neurodegenerative diseases, but have not been investigated in PSP. Therefore, as proof of principle, we sought to identify whether they were dysregulated in matched serum and cerebrospinal fluid (CSF) samples of patients with PSP. Small RNA-seq was undertaken on serum and CSF samples from healthy controls (n = 20) and patients with PSP (n = 31) in two cohorts, with reverse transcription-quantitative PCR (RT-qPCR) to confirm their dysregulation. Using RT-qPCR, we found in serum significant down-regulation in hsa-miR-92a-3p, hsa-miR-626, hsa-piR-31068, and tRNA-ValCAC. In CSF, both hsa-let-7a-5p and hsa-piR-31068 showed significant up-regulation, consistent with their changes observed in the RNA-seq results. Interestingly, we saw no correlation in the expression of hsa-piR-31068 within our matched serum and CSF samples, suggesting there is no common dysregulatory mechanism between the two biofluids. While these changes were in a small cohort of samples, we have provided novel evidence that ncRNA in biofluids could be possible diagnostic biomarkers for PSP and further work will help to expand this potential.

Type: Article
Title: Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.3390/ijms232314554
Publisher version: https://doi.org/10.3390/ijms232314554
Language: English
Additional information: Copyright © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: PSP, RNA-seq, biomarker, non-coding RNA, progressive supranuclear palsy, Humans, Supranuclear Palsy, Progressive, Biomarkers, MicroRNAs, Down-Regulation
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: https://discovery.ucl.ac.uk/id/eprint/10162102
Downloads since deposit
15Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item